Spinal Cord Stimulation and Training

March 31, 2026 updated by: Ismael Seáñez, Washington University School of Medicine

Neural Plasticity by Spinal Cord Stimulation and Training in People With Spinal Cord Injury

This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function.

Study Overview

Detailed Description

The goal of this project is to determine the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal, and spinal neural circuits that are involved in SCS-mediated motor function improvements in individuals with spinal cord injury (SCI). The study will: (1) Determine the short-term effects in neural excitability induced by SCS and activity-based training. (2) Determine the effect of motor training on short-term changes in neural excitability enabled by SCS. (3) Determine the long-term changes in motor control and neural plasticity induced by combined SCS and activity-based training in individuals with chronic SCI. Having a better understanding of the neural mechanisms that are enhanced by SCS can allow the development of therapies that directly target the excitability and plasticity states of these structures towards improved and accelerated recovery.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63130
        • Recruiting
        • Washington University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Healthy Volunteers

  • Age between 16 and 65 years old
  • Healthy people with no major comorbidities of any organ system

Exclusion Criteria:

Healthy Volunteers

  • Subjects younger than 16 or older than 65 years old
  • Subjects not providing consent or not able to consent
  • Subjects with any acute or chronic pain condition
  • Subjects with any acute or chronic disease of a major organ system
  • Use of analgesics within 24 hours prior to study period
  • Use of caffeine with 3 hours of study appointment

Inclusion criteria:

Participants with spinal cord injury (SCI)

  • Age between 16-65 years old
  • Traumatic SCI C4-T9 level, incomplete (ASIA C or D)
  • at least 1 year post injury
  • Stable medical condition
  • difficulty independently performing leg movements in routine activities
  • able to follow simple commands
  • able to speak and respond to questions

Exclusion criteria:

Participants with spinal cord injury (SCI)

  • Subjects younger than 16 or older than 65 years old
  • Not willing or able to provide consent
  • Any acute or chronic pain condition
  • Any acute or chronic disease of a major organ system
  • Use of analgesics within 24 hours prior to study appointment
  • Use of caffeine with 3 hours of study appointment
  • Presence of tremors, spasms and other significant involuntary movements
  • Etiology of SCI other than trauma
  • Concomitant neurologic disease traumatic brain injury (TBI) that will significantly impact the ability to follow through on study directions, multiple sclerosis (MS), stroke or peripheral neuropathy)
  • History of significant medical illness (cardiovascular disease, uncontrolled diabetes, uncontrolled hypertension, osteoporosis, cancer, chronic obstructive pulmonary disease, severe asthma requiring hospitalization for treatment, renal insufficiency requiring dialysis, autonomic dysreflexia, etc).
  • Severe joint contractures disabling or restricting lower limb movements.
  • Unhealed fracture, contracture, pressure sore, urinary tract infection or other uncontrolled infections, other illnesses that might interfere with lower extremity exercises or testing activities
  • Depression, anxiety, or cognitive impairment
  • Deficit of visuospatial orientation
  • Sitting tolerance less than 1 hour
  • Severe hearing or visual deficiency
  • Miss more than 3 appointments without notification
  • Unable to comply with any of the procedures in the protocol
  • Botulinum toxin injection in lower extremity muscles in the prior six months
  • Any passive implants (osteosynthesis material, metallic plates or screws) below T9.
  • Any implanted stimulator in the body (pacemaker, vagus nerve stimulator, etc.)
  • History of alcoholism or another drug abuse
  • Pregnancy (or possible pregnancy)
  • Having an Intrathecal Baclofen Therapy Pump (ITB pump)
  • History of epilepsy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Non-invasive spinal cord stimulation
This arm will receive 30 minutes of transcutaneous spinal cord stimulation as participants rest.
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Experimental: Experimental: Activity-based training
This arm will perform 30 minutes of activity-based training using leg movements.
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Motor task
Experimental: Experimental: Activity-based training wtih non-invasive spinal cord stimulation
This arm will receive transcutaneous spinal cord stimulation as participants perform 30 minutes of activity-based training using leg movements.
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
Experimental: Experimental: Non-invasive spinal cord stimulation and strength training
This arm will receive transcutaneous spinal cord stimulation as participants perform strengthening exercises.
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
Experimental: Experimental: Non-invasive spinal cord stimulation and precision training
This arm will receive transcutaneous spinal cord stimulation as participants perform precision-control and dexterity exercises.
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
Experimental: Experimental: Long-term activity-based training with non-invasive spinal cord stimulation
This arm will receive 4 weeks of activity-based training with transcutaneous spinal cord stimulation
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor evoked potentials amplitude and latency
Time Frame: 30 minutes before and 30 minutes after intervention; 4 weeks
This primary outcome is a measure of changes in corticospinal tract excitability and plasticity as quantified by changes in the amplitude size and onset latency of motor evoked potentials elicited via transcranial magnetic stimulation.
30 minutes before and 30 minutes after intervention; 4 weeks
Reaction time to startle response
Time Frame: 30 minutes before and 30 minutes after intervention; 4 weeks
This primary outcome is a measure of changes in reticulospinal tract excitability after training as quantified by changes in reaction time after a startling auditory stimulus.
30 minutes before and 30 minutes after intervention; 4 weeks
F-wave response persistence
Time Frame: 30 minutes before and 30 minutes after intervention; 4 weeks
This primary outcome is a measure of changes in spinal motoneuron excitability as quantified by changes in the persistence of F-wave responses elicited via peripheral nerve stimulation.
30 minutes before and 30 minutes after intervention; 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in time to completion from baseline
Time Frame: Baseline, 30 minutes, and 4 weeks
Participants will perform cursor control as a computer game. This outcome measure is the time it takes participants to complete each task.
Baseline, 30 minutes, and 4 weeks
Change in movement smoothness
Time Frame: Baseline, 30 minutes, and 4 weeks
This outcome is a measure of changes in movement smoothness when operating the computer cursor with the body.
Baseline, 30 minutes, and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ismael Seanez, PhD, Washington University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 21, 2023

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

July 8, 2022

First Submitted That Met QC Criteria

July 20, 2022

First Posted (Actual)

July 25, 2022

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 31, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Electrophysiology assessment - corticospinal tract

Subscribe